Diverse Applications of Sustained Delivery Therapy in Retinal Vascular Diseases

Diverse Applications of Sustained Delivery Therapy in Retinal Vascular Diseases is organized by Healio, Paradigm Medical Communications, LLC.

Release Date: September  10, 2025
Expiration Date: September 10, 2026

Description:
After decades of waiting, progress in the sustained treatment of retinal vascular diseases is here and advancing rapidly. The port delivery system is now approved for 3 disease states, allowing for treatment of a large and diverse subset of patients. And many other promising sustained delivery therapies are advancing swiftly through the pipeline. What is the science behind these evolving advances, and which patients may be right for them Find out in this unique, DASHboard-style, expert-led activity.

Learning Objectives:
Upon completion of this activity, participants should be able to:

• Describe how controlled release is achieved via novel and emerging sustained delivery technologies in retinal vascular diseases
• Discuss the clinical impact of continuous delivery of anti-vascular endothelial growth factor therapy in retinal vascular diseases
• Articulate the safety of novel and emerging sustained delivery technologies in the treatment of retinal vascular diseases
• Develop individualized, evidence-based treatment plans for patients with retinal vascular diseases.